Creyos

Name: Creyos
Address: 214 King Street W. Suite 210, Toronto, ON, M5H3S6, CA
Telephone: +18333509227

Call Directions Website Contact the business

Cambridge Brain Sciences is a leading web-based platform for the assessment of cognitive function, built for healthcare practitioners and researchers.

Find out more at cambridgebrainsciences.com. Creyos (formerly Cambridge Brain Sciences) is a leading web-based platform for the assessment of brain health. It allows researchers and healthcare providers to obtain accurate, quantified and scientifically-validated measures of key aspects of cognition, including short-term memory, attention, reasoning, and verbal ability. Healthcare providers using Creyos Health also have access to digital versions of many standardized patient health questionnaires.

10/15/2026

🩺 Early detection is becoming increasingly important in dementia care, and it was a key topic of conversation at AAN Fall last week.

As new treatment options emerge for Alzheimer's disease, identifying cognitive impairment early is more important than ever. For neurologists, having access to sensitive, objective cognitive assessments can help identify subtle changes sooner and inform next steps in patient care.

Our Chief Revenue Officer, Jamie Zuckier, and Chief Product Officer, Faraz Shafaghi, were on the conference floor connecting with neurologists about the evolving dementia care landscape and the role of cognitive assessment in supporting earlier detection and intervention.

📍 Thank you to the American Academy of Neurology (AAN) for bringing the neurology community together, and to everyone who stopped by to share their perspectives!

10/14/2026

❤️ 🧠 As of August 2026, the American College of Cardiology recommends screening older adults with cardiovascular disease for cognitive impairment.

About 1 in 3 patients in cardiology clinics have some degree of cognitive impairment, and up to half of those cases go unrecognized.

The ACC statement also notes that screening strategies suited to high-volume cardiac practice have yet to be developed.

In our latest article, Creyos Staff Scientist Sydni Paleczny looks at what the recommendation asks of the tools used to measure cognition.

Read more on the Creyos blog: https://hubs.li/Q04y2sT20

10/09/2026

📍 That’s a wrap on the AMGA Integration Summit!

A big thank you to AMGA for bringing together such a thoughtful group of healthcare leaders, and to everyone who stopped by the Creyos booth to connect with us.

One of the most interesting themes throughout the Summit was how digital tools are actually making their way into healthcare organizations, and what separates promising innovation from something that can be successfully integrated into care.

It was valuable to hear how leaders are thinking about the technologies, partnerships, and ideas that will shape the next phase of healthcare, and what it takes to make those innovations work in practice.

Learn more about how Creyos supports care teams: https://hubs.li/Q04zMXjz0

10/08/2026

🖥️ Did you know Creyos reports can sync straight to the patient's chart?

Creyos integrates with Epic, eClinicalWorks, athenahealth, and AdvancedMD, among other EHRs.

After a one-time setup, completed cognitive and behavioral health reports arrive in the chart automatically, with no downloading, scanning, or uploading by hand.

Creyos Director of Product Anthony Chung walks through how the integrations work and what they change for a practice.

Read more: https://hubs.li/Q04y2q_y0

10/07/2026

🧠 Inattention on a repetitive computer task can be associated with ADHD. It can also reflect anxiety, depression, sleep deprivation, or the effects of a sedative medication.

That overlap in presentation impacts how clinicians interpret continuous performance tests, such as the T.O.V.A., in an ADHD assessment.

A new article looks at what these results can tell you about ADHD, and what else belongs alongside them in a complete evaluation.

Read more: https://hubs.li/Q04y2pZ30

10/06/2026

🧠 What does it take to make brain health a more routine part of healthcare?

That question is front and center at the Alzheimer's Association Health Care Summit, where Creyos Chief Marketing Officer Erin Smith is joining the conversation this week.

Just this morning, the Alzheimer’s Association announced its new Brain Health & Quality Care Initiative, aimed at helping health systems integrate brain health and high-quality dementia care into everyday clinical practice, with an initial focus on primary care.

That’s where the conversation gets especially interesting. How do we make cognitive assessment practical, accessible, and useful enough to become a routine part of care?

We’re excited to see that question getting more attention, and to be part of the conversation at the Summit.

https://hubs.li/Q04zmTyL0

09/29/2026

🧠 ⚕️ Dementia begins as a breakdown in large-scale brain networks 5 to 10 years before obvious symptoms appear.

Health systems route those patients into neurology and geriatrics queues that stretch for months, which defers care during the window when intervention matters most.

One multi-state integrated delivery network redesigned that pathway and moved objective cognitive assessment into primary care.

Our white paper covers:
👉 the science of the detection window
👉 their selection criteria and rollout blueprint
👉 and the financial case under both fee-for-service and value-based care.

The earlier you know, applied at system scale.

Get the white paper: https://hubs.li/Q04y2nwP0

09/28/2026

Awareness is an important part of changing the future of Alzheimer’s and dementia, opening the door to earlier identification, more proactive care, and better support along the care journey.

🧠 Following World Alzheimer’s Day, those conversations feel especially timely.

On October 6-7, Erin Smith, Chief Marketing Officer at Creyos, will be in Houston for the Alzheimer's Association Health Care Summit: Advancing Quality and Innovation.

We’re looking forward to conversations about what it takes to move brain health forward, from awareness to meaningful action in everyday care.

📍 Houston | October 6-7

If you're attending, be sure to say hello!

09/22/2026

🧠 An estimated 15.5 million U.S. adults had an ADHD diagnosis in 2023, according to the CDC. Roughly half were diagnosed as adults.

Each diagnosis initiates years of follow-up:
👉 Is the medication working?
👉 Should the dose change?
👉 Is a shift in symptoms a treatment response, a bad week, or something else?

Most practices answer those questions with rating scales and self-report.

Our latest article looks at how Creyos supports monitoring ADHD over time with objective cognitive data, from baseline through follow-up: https://hubs.ly/Q04y2bQW0

09/21/2026

💜 Today is World Alzheimer's Day, and this year's theme from Alzheimer's Disease International focuses on the value of an earlier diagnosis.

In the US, more than half of older adults diagnosed with dementia receive that diagnosis from a primary care physician. It often happens in a visit of about 18 minutes that also covers many other health concerns.

Our ebook, Confronting the Dementia Crisis, was written for primary care teams. It reviews current best practices for assessing MCI and dementia and includes a checklist for assessing practice readiness.

👉 Download the free ebook here:
https://hubs.li/Q04x-VL10

Address

214 King Street W. Suite 210
Toronto, ON
M5H3S6

Telephone

+18333509227

Website

http://www.creyos.com/

Alerts

Be the first to know and let us send you an email when Creyos posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Creyos:

Want your business to be the top-listed engineering company in Toronto?